US Stock MarketDetailed Quotes
OBSEF OBSEVA SA
- 0.000
- 0.000-90.00%
15min DelayTrading Jul 25 09:31 ET
1.17KMarket Cap0.00P/E (TTM)
0.000High0.000Low200Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)117.18MShares0.60052wk High0.00P/B1.17KFloat Cap0.00052wk Low--Dividend TTM117.18MShs Float0.600Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About OBSEVA SA Company
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.
Company Profile
SymbolOBSEF
Company NameOBSEVA SA
Listing DateJan 26, 2017
Founded2012
MarketPink Market
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressChemin des Aulx, 12,Plan-les-Ouates
CityGeneva
ProvinceGeneve (Geneva)
CountrySwitzerland
Zip Code1228
Phone41-22-552-38-40
Websitehttp://www.obseva.com
Company Executives
- Name
- Position
- Salary
- Will Brown
- Interim Chief Executive Officer and Chief Financial Officer
- --
- Brian OCallaghan
- Director
- --
- Stephanie Brown
- Independent Director
- --
- Ed Mathers
- Independent Director
- --
- Catarina Edfjall
- Independent Director
- --
- Anne VanLent
- Independent Director
- --
- Ernest Loumaye
- Interim Chiarman of the Board
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
